Interbiome Partners
Interbiome Partners launches businesses and cooperative civic ventures focused on improving cultural inter-connectivity and aggregate interaction rates. The firm applies these methods to Population Health by creating and operating contract drug-manufacturing organizations (CMOs), remodeling and expanding cGMP facilities, and supporting a related nonprofit (Interbiome Foundation) to address neglected and abandoned drugs within the public health supply chain.
Services
Launch and management of subsidiary CMOs
Incorporates and operates contract manufacturing organizations, including remodeling and commissioning cGMP drug-manufacturing facilities for commercial and clinical production.
Population Health Supply Chain (PHSC) initiatives
Develops and funds programs aimed at improving net interaction rates across the population health supply chain, including alignment with the Interbiome Foundation's milestone goals.
Collaborative development and capital recruitment for facilities
Recruits collaborators to participate in purchase, construction and operation of additional drug-manufacturing facilities to expand manufacturing capacity.
Operational contracting to external biopharma firms
Provides facility space and cGMP-capable infrastructure for external companies under contract (example: an exclusive contract with Vigene Biosciences for facility use).
Launch and management of subsidiary CMOs
Incorporates and operates contract manufacturing organizations, including remodeling and commissioning cGMP drug-manufacturing facilities for commercial and clinical production.
Population Health Supply Chain (PHSC) initiatives
Develops and funds programs aimed at improving net interaction rates across the population health supply chain, including alignment with the Interbiome Foundation's milestone goals.
Collaborative development and capital recruitment for facilities
Recruits collaborators to participate in purchase, construction and operation of additional drug-manufacturing facilities to expand manufacturing capacity.
Operational contracting to external biopharma firms
Provides facility space and cGMP-capable infrastructure for external companies under contract (example: an exclusive contract with Vigene Biosciences for facility use).
Portfolio
Remodeled an 11,000 ft2 abandoned CMO facility in Rockville, MD; expanded to ~26,000 ft2; completed IQ/OQ and hosted Vigene Biosciences operations in 2018.
#Contract drug manufacturing / cGMP biomanufacturing
Established to define and fund milestone goals for Population Health and the Population Health Supply Chain (PHSC).
#Nonprofit / Population health initiatives
Planned additional facilities targeting ~30,000 sq ft per site in Maryland and other regions.
#Contract drug manufacturing / facility development
Contracted for 2-year exclusive use of Interbiome's Gude Dr cGMP facility through Sept 30, 2020.
#Biotechnology / gene delivery
Remodeled an 11,000 ft2 abandoned CMO facility in Rockville, MD; expanded to ~26,000 ft2; completed IQ/OQ and hosted Vigene Biosciences operations in 2018.
#Contract drug manufacturing / cGMP biomanufacturing
Established to define and fund milestone goals for Population Health and the Population Health Supply Chain (PHSC).
#Nonprofit / Population health initiatives
Planned additional facilities targeting ~30,000 sq ft per site in Maryland and other regions.
#Contract drug manufacturing / facility development
Contracted for 2-year exclusive use of Interbiome's Gude Dr cGMP facility through Sept 30, 2020.
#Biotechnology / gene delivery